The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study (original) (raw)

References

  1. Armitage JO . Bone marrow transplantation. N Engl J Med 1994; 330: 827–838.
    Article CAS Google Scholar
  2. Yeager AM . Allogeneic hematopoietic cell transplantation in inborn metabolic diseases. Ann Hematol 2002; 81: S16–S19.
    Article CAS Google Scholar
  3. Burt RK, Traynor AE, Craig R, Marmont AM . The promise of hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2003; 31: 521–524.
    Article CAS Google Scholar
  4. Wingard JR, Vogelsang GB, Deeg HJ . Stem cell transplantation: supportive care and long-term complications. Hematology 2002, 422–444.
    Article Google Scholar
  5. Tabbara IA, Zimmerman K, Morgan C, Nahleh Z . Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med 2002; 162: 1558–1566.
    Article Google Scholar
  6. Antin JH, Chen AR, Couriel DR, Ho VT, Nash RA, Weisdorf D . Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease. Biol Blood Marrow Transplant 2004; 10: 655–668.
    Article CAS Google Scholar
  7. Van Lint MT, Milone G, Leotta S, Uderzo C, Scime R, Dallorso S et al. Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin. Blood 2006; 107: 4177–4181.
    Article CAS Google Scholar
  8. Ferrara JL, Deeg HJ . Graft-versus-host disease. N Engl J Med 1991; 324: 667–674.
    Article CAS Google Scholar
  9. Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW et al. Depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120–2130.
    CAS Google Scholar
  10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.
    Article CAS Google Scholar
  11. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC et al. Clarification of the nomenclature for MSC: the international society for cellular therapy position statement. Cytotherapy 2005; 7: 393–395.
    Article CAS Google Scholar
  12. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI et al. Rapid hematopoietic recovery after co-infusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307–316.
    Article CAS Google Scholar
  13. Angelopoulou M, Novelli E, Grove JE, Rinder HM, Civin C, Cheng L et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 2003; 31: 413–420.
    Article CAS Google Scholar
  14. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42–48.
    Article Google Scholar
  15. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722–3729.
    Article CAS Google Scholar
  16. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC . Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389–397.
    Article CAS Google Scholar
  17. Frassoni F, Labopin M, Bacigalupo A, Gluckman E, Rocha V, Bruno B et al. Expanded mesenchymal stem cells (MSC), co-infused with HLA identical hematopoietic stem cells transplants, reduce acute and chronic graft-versus-host disease: a matched pair analysis in hematologic malignancy patients. Bone Marrow Transplant 2002; 29 (suppl 2): S2 [Abstract 75].
  18. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439–1441.
    Article Google Scholar
  19. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102: 3837–3844.
    Article CAS Google Scholar
  20. Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003; 9: 1269–1274.
    Article CAS Google Scholar
  21. Olerup O, Zetterquist H . HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 h: an alternative to serological DR typing in clinical practice including donorrecipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225–235.
    Article CAS Google Scholar
  22. Copelan EA, Biggs JC, Szer J, Thompson JM, Crilley P, Brodsky I et al. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2). Semin Oncol 1993; 20 (4 suppl 4): 33–38.
    CAS Google Scholar
  23. Socié G, Clift RA, Blaise D, Devergie A, Ringden O, Martin PJ et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood 2001; 98: 3569–3574.
    Article Google Scholar
  24. Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 84: 2036–2043.
    CAS Google Scholar
  25. Storb R, Deeg HJ, Fisher L, Appelbaum F, Buckner CD, Bensinger W et al. Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials. Blood 1988; 71: 293–298.
    CAS Google Scholar
  26. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.
    CAS Google Scholar
  27. Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM . Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Bone Marrow Transplant 1989; 4: 247–254.
    CAS Google Scholar
  28. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42–48.
    Article Google Scholar
  29. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838–3843.
    Article CAS Google Scholar
  30. Troeger A, Meisel R, Moritz T, Dilloo D . Immunotherapy in allogeneic hematopoietic stem cell transplantation—not just a case for effector cells. Bone Marrow Transplant 2005; 35: S59–S64.
    Article Google Scholar
  31. Ramasamy R, Lam EW-F, Soeiro I, Tisato V, Bonnet D, Dazzi F . Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 2007; 21: 304–310.
    Article CAS Google Scholar
  32. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389–398.
    Article Google Scholar
  33. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H et al. Mesenchymal stem cells for treatment of therapy resistant graft-versus-host disease. Transplantation 2006; 81: 1390–1397.
    Article Google Scholar
  34. Schmitz N, Bacigalupo A, Hasenclever D, Nagler A, Gluckman E, Clark P et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European group for blood and marrow transplantation. Bone Marrow Transplant 1998; 21: 995–1003.
    Article CAS Google Scholar
  35. Powles R, Mehta J, Kulkarni S, Treleaven J, Millar B, Marsden J et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet 2000; 355: 1231–1237.
    Article CAS Google Scholar
  36. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175–181.
    Article CAS Google Scholar
  37. Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 2000; 95: 3702–3709.
    CAS Google Scholar
  38. Couban S, Simpson DR, Barnett MJ, Bredeson C, Hubesch L, Howson-Jan K et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002; 100: 1525–1531.
    Article CAS Google Scholar
  39. Tisato V, Naresh K, Girldstone J, Navarrete C, Dazzi F . Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease. Leukemia 2007; 21: 1992–1999.
    Article CAS Google Scholar
  40. Lazarus HM, Koc ON . Culture-expanded human marrow derived MSCs in clinical hematopoietic stem cell transplantation. Graft 2001; 3: 329–333.
    Google Scholar
  41. Koc ON, Lazarus HM . Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 2001; 27: 235–239.
    Article CAS Google Scholar
  42. Park S-K, Won J-H, Kim H-J, Bae S-B, Kim C-K, Lee K-T et al. Co-transplantation of human mesenchymal stem cells promotes human CD34+ cells engraftment in a dose-dependent fashion in NOD/SCID mice. J Korean Med Sci 2007; 22: 412–419.
    Article Google Scholar

Download references